PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITORS - BIOCHEMICAL ASPECTS

被引:61
作者
RIJKEN, DC
机构
来源
BAILLIERES CLINICAL HAEMATOLOGY | 1995年 / 8卷 / 02期
关键词
D O I
10.1016/S0950-3536(05)80269-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although this chapter does not represent a historical review, it will be clear how the biochemistry of t-PA, u-PA, PAI-1 and PAI-2 has evolved and where we stand in 1994. While the functional activities of the proteins were recognized at least three to four decades ago, highly purified preparations became available around 1980. In the mid-eighties the cDNAs of the proteins were cloned, representing a major breakthrough in the biochemistry of the four proteins. Amino acid sequences were derived from the nucleotide sequences, homologies with other proteins were recognized and larger amounts of (recombinant) proteins became available for research. In addition, mutant proteins were prepared by recombinant DNA technology, enabling investigation of structure-function relationships. This report is mainly based on the latter studies. Detailed information about three-dimensional structures of the proteins and the mode of interaction with other macromolecules is still lacking. To obtain this information will be the goal for biochemists in the coming years. © 1995 Baillière Tindall. All rights reserved.
引用
收藏
页码:291 / 312
页数:22
相关论文
共 128 条
[41]  
Holmes, Pennica, Blaber, Et al., Cloning and Expression of the Gene for Pro-urokinase in Escherichia coli, Bio/Technology, 3, pp. 923-929, (1985)
[42]  
Horrevoets, Smilde, De Vries, Pannekoek, The specific roles of finger and kringle 2 domains of tissue-type plasminogen activator during in vitro fibrinolysis, The Journal of Biological Chemistry, 269, pp. 12639-12644, (1994)
[43]  
Horrevoets, Tans, Smilde, Et al., Thrombin-variable region 1 (VR1), The Journal of Biological Chemistry, 268, pp. 779-782, (1993)
[44]  
Hoylaerts, Rijken, Lijnen, Collen, Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin, The Journal of Biological Chemistry, 257, pp. 2912-2919, (1982)
[45]  
Husain, Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities, Biochemistry, 30, pp. 5797-5805, (1991)
[46]  
Husain, Fibrin affinity of urokinase-type plasminogen activator. Evidence that Zn<sup>2+</sup> mediates strong and specific interaction of single-chain urokinase with fibrin, The Journal of Biological Chemistry, 268, pp. 8574-8579, (1993)
[47]  
Kaczmarek, Lee, McDonagh, Initial interaction between fibrin and tissue plasminogen activator (t-PA). The Gly-Pro-Arg-Pro binding site on fibrin(ogen) is important for t-PA activity, The Journal of Biological Chemistry, 268, pp. 2474-2479, (1993)
[48]  
Kaneko, Sakata, Matsuda, Mimuro, Interactions between the finger and kringle-2 domains of tissue-type plasminogen activator and plasminogen activator inhibitor-1, Journal of Biochemistry, 111, pp. 244-248, (1992)
[49]  
Kawano, Morimoto, Uemura, Urokinase inhibitor in human placenta, Nature, 217, pp. 253-254, (1968)
[50]  
Keijer, Linders, Wegman, Et al., On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site, Blood, 78, pp. 1254-1261, (1991)